ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 220
Summary
- Conditions
- Appendix Cancer
- Colorectal Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Single Group AssignmentIntervention Model Description: After the initial 212 patients are accrued, the final 70 patients will be accrued to only the appendiceal cohortsMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01815359
- Collaborators
- The Cleveland Clinic
- Brigham and Women's Hospital
- University of Miami
- University of Pittsburgh Medical Center
- Washington University School of Medicine
- Investigators
- Principal Investigator: Garrett Nash, MD, MPH Memorial Sloan Kettering Cancer Center
Get Well Soon